Atrial Fibrillation
Atrial fibrillation (AF) is a common heart condition characterized by an irregular and often rapid heartbeat, which can lead to various complications, including stroke and heart failure.
Atrial Fibrillation: Warfarin Study for Dialysis Patients
We are investigating the safety and effectiveness of warfarin in patients with atrial fibrillation who are on dialysis. This study aims to understand how this medication impacts their health.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
End-Stage Renal Disease
End-stage renal disease (ESRD) is the final stage of chronic kidney disease, where the kidneys can no longer function adequately to meet the body's needs, often requiring dialysis or a kidney transplant.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have a diagnosis of atrial fibrillation (irregular heartbeat) that has not been treated for more than 2 months?
- Are you currently pregnant or breastfeeding?
- Are you taking any blood thinners like Warfarin, Eliquis, or Xarelto?
- Have you had any major bleeding issues that would prevent you from taking blood thinners?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Aldocumar
Coumadin
Coumadin®
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Aalborg University Hospital
Nephrology
Aalborg, Denmark
Aarhus University Hospital
Nephrology
Århus, Denmark
Rigshospitalet
Nephrology
Copenhagen, Denmark
Sponsor: Rigshospitalet
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.